ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting Sleeping Beauty ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting Shirley P. Olin 21/03/2022 6:53 AM – Clinical data show continued survival benefit, tumor response, and multi-year persistence of Sleeping Beauty-modified CD19-specific CAR+... Read More Read more about ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting
.jpg "Fashion Predictions for 2025: What to Expect")
